Chargement en cours...
HIF-1 Dimerization Inhibitor Acriflavine Enhances Antitumor Activity of Sunitinib in Breast Cancer Model
Antiangiogenic therapy is a promising strategy for cancer therapy. However, antiangiogenic therapy can induce intratumor hypoxia and hypoxia-inducible factor-1 (HIF-1) expression, which slows cancer progression. In our present study, we found that antiangiogenic therapy with sunitinib plus HIF-1 dim...
Enregistré dans:
| Publié dans: | Oncol Res |
|---|---|
| Auteurs principaux: | , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Cognizant Communication Corporation
2015
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7838425/ https://ncbi.nlm.nih.gov/pubmed/26168132 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3727/096504014X13983417587366 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|